[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2013 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-Aug-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Jun-2013 [#2]
Profit Trend
QoQ- -38.16%
YoY- -31.0%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 1,874,688 1,946,639 1,838,372 1,875,944 2,001,356 1,812,346 1,773,256 3.78%
PBT 152,636 92,997 79,986 93,058 147,696 103,313 132,088 10.12%
Tax -46,052 -36,236 -32,661 -30,410 -47,084 -40,108 -37,856 13.97%
NP 106,584 56,761 47,325 62,648 100,612 63,205 94,232 8.56%
-
NP to SH 104,868 55,200 45,849 61,272 99,084 61,710 92,860 8.45%
-
Tax Rate 30.17% 38.96% 40.83% 32.68% 31.88% 38.82% 28.66% -
Total Cost 1,768,104 1,889,878 1,791,046 1,813,296 1,900,744 1,749,141 1,679,024 3.50%
-
Net Worth 515,022 486,754 473,857 481,681 484,829 471,886 496,623 2.45%
Dividend
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Div 41,408 41,477 33,903 35,323 35,303 41,187 39,227 3.67%
Div Payout % 39.49% 75.14% 73.95% 57.65% 35.63% 66.74% 42.24% -
Equity
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Net Worth 515,022 486,754 473,857 481,681 484,829 471,886 496,623 2.45%
NOSH 258,805 258,911 258,938 258,968 117,676 117,677 117,683 69.19%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin 5.69% 2.92% 2.57% 3.34% 5.03% 3.49% 5.31% -
ROE 20.36% 11.34% 9.68% 12.72% 20.44% 13.08% 18.70% -
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
RPS 724.36 751.85 709.97 724.39 1,700.72 1,540.10 1,506.80 -38.66%
EPS 40.52 21.32 17.71 23.66 84.20 52.44 78.91 -35.90%
DPS 16.00 16.02 13.09 13.64 30.00 35.00 33.33 -38.71%
NAPS 1.99 1.88 1.83 1.86 4.12 4.01 4.22 -39.44%
Adjusted Per Share Value based on latest NOSH - 258,370
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
RPS 130.07 135.07 127.55 130.16 138.86 125.75 123.04 3.77%
EPS 7.28 3.83 3.18 4.25 6.87 4.28 6.44 8.52%
DPS 2.87 2.88 2.35 2.45 2.45 2.86 2.72 3.64%
NAPS 0.3573 0.3377 0.3288 0.3342 0.3364 0.3274 0.3446 2.44%
Price Multiplier on Financial Quarter End Date
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Date 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 -
Price 4.46 4.45 4.82 4.49 8.26 8.10 7.55 -
P/RPS 0.62 0.59 0.68 0.62 0.49 0.53 0.50 15.43%
P/EPS 11.01 20.87 27.22 18.98 9.81 15.45 9.57 9.80%
EY 9.09 4.79 3.67 5.27 10.19 6.47 10.45 -8.88%
DY 3.59 3.60 2.72 3.04 3.63 4.32 4.42 -12.95%
P/NAPS 2.24 2.37 2.63 2.41 2.00 2.02 1.79 16.14%
Price Multiplier on Announcement Date
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Date 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 -
Price 4.70 4.29 4.72 4.66 9.26 7.80 8.25 -
P/RPS 0.65 0.57 0.66 0.64 0.54 0.51 0.55 11.79%
P/EPS 11.60 20.12 26.66 19.70 11.00 14.87 10.46 7.14%
EY 8.62 4.97 3.75 5.08 9.09 6.72 9.56 -6.67%
DY 3.40 3.73 2.77 2.93 3.24 4.49 4.04 -10.87%
P/NAPS 2.36 2.28 2.58 2.51 2.25 1.95 1.95 13.58%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment